{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:07:50Z","timestamp":1768734470395,"version":"3.49.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ijcha.2018.02.009","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T17:58:29Z","timestamp":1520877509000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Angiotensin, transforming growth factor \u03b2 and aortic dilatation in Marfan syndrome: Of mice and humans"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1025-5480","authenticated-orcid":false,"given":"Christopher","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richmond W.","family":"Jeremy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9501","key":"10.1016\/j.ijcha.2018.02.009_bb0005","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","article-title":"Marfan's syndrome","volume":"366","author":"Judge","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.2005.039669","article-title":"The molecular genetics of Marfan syndrome and related disorders","volume":"43","author":"Robinson","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0015","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.108.841981","article-title":"Circulating transforming growth factor-\u03b2 in Marfan syndrome","volume":"120","author":"Matt","year":"2009","journal-title":"Circulation"},{"issue":"Suppl. I","key":"10.1016\/j.ijcha.2018.02.009_bb0020","first-page":"I-371","article-title":"Overexpression of transforming growth factor-\u03b2 Is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm","volume":"114","author":"Nataatmadja","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0025","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/01.CIR.0000165133.84978.E2","article-title":"Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism","volume":"111","author":"Rodriguez-Vita","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0030","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5770","key":"10.1016\/j.ijcha.2018.02.009_bb0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0040","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","article-title":"Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial","volume":"34","author":"Groenink","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0045","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","article-title":"Marfan Sartan: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Milleron","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0050","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0055","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan's syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0060","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/eurheartj\/ehv575","article-title":"Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial","volume":"37","author":"Forteza","year":"2016","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcha.2018.02.009_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004968","article-title":"Aortopathy in a mouse model of Marfan syndrome is not mediated by altered transforming growth factor-\u03b2 signaling","volume":"6","author":"Wei","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0070","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/CIRCRESAHA.116.310371","article-title":"The pathogenic transforming growth factor-\u03b2 overdrive hypothesis in aortic aneurysms and dissections: a mirage?","volume":"120","author":"Mallat","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2013.08.056","article-title":"Perturbations of mechanotransduction and aneurysm formation in heritable aortopathies","volume":"169","author":"Jeremy","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/CIRCGENETICS.112.964064","article-title":"TGF\u03b2RII mutations trigger aortic aneurysm pathogenesis by altering TGF\u03b22 signal transduction","volume":"5","author":"Bee","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0085","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1136\/heartjnl-2016-310631","article-title":"Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome","volume":"103","author":"Franken","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0090","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1093\/eurheartj\/ehv739","article-title":"Genotype impacts survival in Marfan syndrome","volume":"37","author":"Franken","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/341581","article-title":"Premature termination mutations in FBN1: distinct effects on differential allelic expression and on protein and clinical phenotypes","volume":"71","author":"Schrijver","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1172\/JCI200420641","article-title":"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome","volume":"114","author":"Judge","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ijcha.2018.02.009_bb0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1083\/jcb.50.1.159","article-title":"The smooth muscle cell. I. In vivo synthesis of connective tissue proteins","volume":"50","author":"Ross","year":"1971","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0110","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/CIRCRESAHA.117.311450","article-title":"Unspliced XBP1 confers VSMC homeostasis and prevents aortic aneurysm formation via FoxO4 interaction","volume":"121","author":"Zhao","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0115","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jtcvs.2009.07.075","article-title":"Smooth muscle phenotypic modulation is an early event in aortic aneurysms","volume":"138","author":"Ailawadi","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"4","key":"10.1016\/j.ijcha.2018.02.009_bb0120","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/ATVBAHA.114.304412","article-title":"Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome","volume":"35","author":"Crosas-Molist","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.ijcha.2018.02.009_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186603","article-title":"Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan syndrome","volume":"12","author":"Dale","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1470320309347785","article-title":"The angiotensin II type 2 receptor in cardiovascular disease","volume":"11","author":"Lemarie","year":"2010","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0135","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.CIR.99.3.392","article-title":"Role of extracellular signal-regulated kinases in angiotensin II\u2013stimulated contraction of smooth muscle cells from human resistance arteries","volume":"99","author":"Touyz","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0140","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.98.22.2453","article-title":"Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms","volume":"98","author":"Nickenig","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0145","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/00004872-199816120-00007","article-title":"Erythropoietin upregulates angiotensin receptors in cultured rat vascular smooth muscle cells","volume":"16","author":"Barrett","year":"1998","journal-title":"J. Hypertens."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcha.2018.02.009_bb0150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.HYP.31.1.342","article-title":"Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide","volume":"31","author":"Ichiki","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0014-2999(95)00771-7","article-title":"Regulation of angiotensin AT1 receptor gene expression during cell growth of vascular smooth muscle cells","volume":"297","author":"Nickenig","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0160","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00439.2003","article-title":"Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells","volume":"287","author":"Taniyama","year":"2004","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0165","doi-asserted-by":"crossref","first-page":"14169","DOI":"10.1074\/jbc.271.24.14169","volume":"271","author":"Eguchi","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0170","first-page":"367","article-title":"Requirement of Ca(2+) and PKC\u03b4 for Janus kinase 2 activation by angiotensin II: involvement of PYK2","volume":"16","author":"Frank","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0175","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H oxidase: role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ. Res."},{"issue":"14","key":"10.1016\/j.ijcha.2018.02.009_bb0180","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0185","article-title":"Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration","volume":"5","author":"Zhang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0190","doi-asserted-by":"crossref","first-page":"H801","DOI":"10.1152\/ajpheart.00908.2011","article-title":"Angiotensin-(1\u20137) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1","volume":"302","author":"McCollum","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0195","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0022-3565(25)38196-6","article-title":"Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved","volume":"265","author":"Jaiswal","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0200","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/CS20130436","article-title":"Angiotensin-(1\u20137) and angiotensin-(1\u20139): function in cardiac and vascular remodelling","volume":"126","author":"McKinney","year":"2014","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0205","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0210","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/HYPERTENSIONAHA.111.177485","article-title":"Angiotensin-(1\u20139) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor","volume":"59","author":"Flores-Munoz","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0215","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nrm2297","article-title":"TGF\u03b2-SMAD signal transduction: molecular specificity and functional flexibility","volume":"8","author":"Schmierer","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0220","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","article-title":"Specificity and versatility in tgf-beta signaling through Smads","volume":"21","author":"Feng","year":"2005","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0225","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cardiores.2007.02.008","article-title":"TGF-\u03b2 signaling in vascular fibrosis","volume":"74","author":"Ruiz-Ortega","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"16","key":"10.1016\/j.ijcha.2018.02.009_bb0230","doi-asserted-by":"crossref","first-page":"12477","DOI":"10.1074\/jbc.C100008200","article-title":"Smurf1 interacts with transforming growth factor-\u03b2 type I receptor through Smad7 and induces receptor degradation","volume":"276","author":"Ebisawa","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0235","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ncb975","article-title":"Distinct endocytic pathways regulate TGF-\u03b2 receptor signalling and turnover","volume":"5","author":"Di Guglielmo","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0240","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bbadis.2017.11.015","article-title":"Altered TGF-\u03b2 endocytic trafficking contributes to the increased signaling in Marfan syndrome","volume":"1864","author":"Siegerta","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0245","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/cvr\/cvq291","article-title":"Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms","volume":"89","author":"Gomez","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0250","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bbaexp.2006.11.001","article-title":"Regulation of Smad activities","volume":"1759","author":"Xu","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0255","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1101\/gad.13.7.804","article-title":"A mechanism of repression of TGFbeta\/Smad signaling by oncogenic Ras","volume":"13","author":"Kretzschmar","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0260","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.tcb.2010.06.006","article-title":"Signaling by members of the TGF-\u03b2 family in vascular morphogenesis and disease","volume":"20","author":"Pardali","year":"2010","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.ijcha.2018.02.009_bb0265","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2353\/ajpath.2009.080565","volume":"174","author":"Thomas","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"20","key":"10.1016\/j.ijcha.2018.02.009_bb0270","doi-asserted-by":"crossref","first-page":"13874","DOI":"10.1074\/jbc.M707820200","article-title":"Targeting of bone morphogenetic protein growth factor complexes to fibrillin","volume":"283","author":"Sengle","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1242\/jcs.076505","article-title":"T\u03b2RI\/Alk5-independent T\u03b2RII signaling to ERK1\/2 in human skin cells according to distinct levels of T\u03b2RII expression","volume":"124","author":"Bandyopadhyay","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/cr.2008.327","article-title":"Phospho-control of TGF-\u03b2 superfamily signaling","volume":"19","author":"Wrighton","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0285","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/ATVBAHA.114.305150","article-title":"Dimorphic effects of transforming growth factor-\u03b2 signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome","volume":"35","author":"Cook","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.ijcha.2018.02.009_bb0290","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI69666","article-title":"Angiotensin II\u2013dependent TGF-\u03b2 signaling contributes to Loeys-Dietz syndrome vascular pathogenesis","volume":"124","author":"Gallo","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ijcha.2018.02.009_bb0295","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1172\/JCI117251","article-title":"Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells","volume":"93","author":"Kagami","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0300","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3317\/jraas.2000.064","article-title":"Transforming growth factor-\u03b21 induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts","volume":"1","author":"Petrov","year":"2000","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0305","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000089129.51288.BA","article-title":"Connective tissue growth factor is a mediator of angiotensin II\u2013induced fibrosis","volume":"108","author":"Ruperez","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0310","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1172\/JCI38136","article-title":"TGF-\u03b2 activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice","volume":"120","author":"Wang","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.ijcha.2018.02.009_bb0315","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003705","article-title":"Ventricular-vascular coupling in Marfan and non-Marfan aortopathies","volume":"5","author":"Loeper","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"10","key":"10.1016\/j.ijcha.2018.02.009_bb0320","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1007\/s10439-016-1616-4","article-title":"Losartan attenuates degradation of aorta and lung tissue micromechanics in a mouse model of severe Marfan syndrome","volume":"44","author":"Lee","year":"2016","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0325","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1192149","article-title":"Noncanonical TGF\u03b2 signaling contributes to aortic aneurysm progression in Marfan syndrome mice","volume":"332","author":"Holm","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0330","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCRESAHA.111.253740","article-title":"miR-29b participates in early aneurysm development in Marfan syndrome","volume":"110","author":"Merk","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0335","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jtcvs.2009.10.039","article-title":"Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome","volume":"140","author":"Yang","year":"2010","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0340","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1093\/hmg\/ddq409","article-title":"Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome","volume":"19","author":"Nistala","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0345","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1192152","article-title":"Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism","volume":"332","author":"Habashi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0350","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1161\/CIRCRESAHA.108.174367","article-title":"Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix etalloproteinase-2 and -9","volume":"102","author":"Chung","year":"2008","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.ijcha.2018.02.009_bb0355","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1358863X15569868","article-title":"Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome","volume":"20","author":"Bhatt","year":"2015","journal-title":"Vasc. Med."},{"issue":"3","key":"10.1016\/j.ijcha.2018.02.009_bb0360","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mayocp.2012.11.005","article-title":"Losartan added to \u03b2-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study","volume":"88","author":"Chiu","year":"2013","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.ijcha.2018.02.009_bb0365","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/00015385.2017.1314134","article-title":"Efficacy of losartan as add-on therapy to prevent aortic growth and ventricular dysfunction in patients with Marfan syndrome: a randomized, double-blind clinical trial","volume":"72","author":"Muino-Mosquera","year":"2017","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0370","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ijcard.2014.11.082","article-title":"A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys\u2013Dietz syndromes","volume":"179","author":"Sandor","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0375","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ahj.2015.01.011","article-title":"Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: a report from the Marfan Treatment trialists' Collaboration","volume":"169","author":"Pitcher","year":"2015","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0380","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/eurheartj\/ehq258","article-title":"Cardiovascular manifestations in men and women carrying a FBN1 mutation","volume":"31","author":"Detaint","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0385","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","article-title":"Beneficial outcome of Losartan therapy depends on type of FBN1 mutation in Marfan syndrome","volume":"8","author":"Franken","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0390","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12471-014-0622-0","article-title":"The revised role of TGF-\u03b2 in aortic aneurysms in Marfan syndrome","volume":"23","author":"Franken","year":"2015","journal-title":"Neth. Hear. J."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0395","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1745-6215-11-3","article-title":"Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial","volume":"11","author":"Radonic","year":"2010","journal-title":"Trials"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0400","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.CIR.94.4.698","article-title":"Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients","volume":"94","author":"Benetos","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2018.02.009_bb0405","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jtcvs.2011.12.038","article-title":"Angiotensin-converting enzyme insertion\/deletion polymorphism is a risk factor for thoracic aortic aneurysm in patients with bicuspid or tricuspid aortic valves","volume":"144","author":"Foffa","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0410","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGF\u03b2 signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijcha.2018.02.009_bb0415","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.108.192492","article-title":"Searching for miR-acles in cardiac fibrosis","volume":"104","author":"van Rooij","year":"2009","journal-title":"Circ. Res."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906717300714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906717300714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:48:08Z","timestamp":1751482088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906717300714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":83,"alternative-id":["S2352906717300714"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2018.02.009","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin, transforming growth factor \u03b2 and aortic dilatation in Marfan syndrome: Of mice and humans","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2018.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}